Replay available

Genomma Lab Intl Sab Ord (GNMLF) Q2 2026 Earnings Call

Genomma Lab Intl Sab Ord (OTC: GNMLF) Q2 2026 earnings conference call, held 2026-07-23. Replay captured from the company's public earnings webcast.

Thu, July 23, 2026 at 1:00 PMendedReplay
Genomma Lab Intl Sab Ord (GNMLF) Q2 2026 Earnings Call

Hosted by

Featured presenters

Christianne Ibáñez

Head of Investor Relations

Marco Sparvieri

Chief Executive Officer

Antonio Zamora

Chief Financial Officer

Alvaro Garcia

Analyst, BTG Paxful

Alejandro Fuch

Analyst, Itao

JP Morgan Analyst

Analyst

Antonio Hernandez

Analyst, Actimber

Regina Carrillo

Analyst, GBM

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Genomma Lab Internacional Sab De Cv Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.953 Good day, ladies and gentlemen. Thank you for joining Genoma Lab's second quarter 2026 00:00:04.953 -- 00:00:10.996 earnings conference call. All participants will be in listen-only mode. 00:00:10.996 -- 00:00:15.799 After today's presentation, there will be an opportunity to ask questions. 00:00:15.799 -- 00:00:20.861 As a reminder, this meeting is being recorded and will be available for replay from 00:00:20.861 -- 00:00:25.980 the investor relations section of Genoma's website following the call. 00:00:25.980 -- 00:00:30.778 I'll now turn the call over to Christianne Ibáñez, Genoma's Head of Investor Relations. 00:00:30.778 -- 00:00:33.179 Please go ahead. 00:00:33.632 -- 00:00:38.773 Thank you and welcome everyone. On today's call are Marco Sparvieri, Chief 00:00:38.773 -- 00:00:43.434 Executive Officer, and Antonio Zamora, Chief Financial Officer. 00:00:43.434 -- 00:00:49.056 Before we get started, I'd like to remind you that the remarks today will include forward-looking 00:00:49.056 -- 00:00:53.897 statements such as the company's financial guidance and expectations, 00:00:53.897 -- 00:00:59.338 including long-term objectives and forecasts, as well as expectations regarding Genoma's 00:00:59.338 -- 00:01:03.879 business, products, strategies, demand, and markets. 00:01:03.879 -- 00:01:09.082 These statements are subject to risks and uncertainties that could cause actual results 00:01:09.082 -- 00:01:14.525 to differ materially. They are also based on assumptions as of today, and the company 00:01:14.525 -- 00:01:19.708 undertakes no obligation to update them as a result of new information or 00:01:19.708 -- 00:01:24.231 future events. Now, let me turn the call over to Mr. 00:01:24.231 -- 00:01:27.528 Marco Sparvieri. Please ...